Regarding the potential usefulness of SIRT2 inhibitors as pharmacological treatments for neurodegenerative diseases, the implication of HDACs in gene expression and the associated potential for DNA toxicity upon their inhibition present a major concern. Here, SIRT2 is linked to neurodegenerative disease.